Mutations
PSEN2 T388M
Quick Links
Overview
Pathogenicity: bvFTD : Not Classified
Clinical
Phenotype: bvFTD
Position: (GRCh38/hg38):Chr1:226894097 C>T
Position: (GRCh37/hg19):Chr1:227081798 C>T
dbSNP ID: rs143549266
Coding/Non-Coding: Coding
DNA
Change: Substitution
Expected RNA
Consequence: Substitution
Expected Protein
Consequence: Missense
Codon
Change: ACG to ATG
Reference
Isoform: PSEN2 Isoform 1 (448 aa)
Genomic
Region: Exon 12
Findings
This variant was found in a screen of 16 dementia genes by whole-exome sequencing in Spanish patients with early onset dementia (Ramos-Campoy et al., 2020). The carrier was diagnosed with behavioral variant frontal temporal dementia with age at onset of 45 years. They were homozygous for the APOE3 allele, and had no family history of dementia.
Thirty-two heterozygotes were reported in the gnomAD variant database, 31 with European ancestry. The global frequency was 0.0001132 (gnomAD v2.1.1, Oct 2021).
Neuropathology
Neuropathological data are unavailable. The reported carrier’s levels of cerebrospinal spinal fluid biomarkers, Aβ42, tau, and phospho-tau, were not consistent with AD (Ramos-Campoy et al., 2020).
Biological Effect
The biological effect of this variant is unknown, but all eight of the in silico algorithms applied (SIFT, Polyphen-2, LRT, Mutation Taster, Mutation Assesor, FATHMM, Radial SVM, and LR) predicted a damaging effect (Ramos-Campoy et al., 2020). Consistently, its PHRED-scaled CADD score (29), which integrates diverse information in silico, was above the commonly used deleteriousness threshold of 20. Ramos-Campoy and colleagues classified it as a variant of uncertain significance according to Richards et al., 2015 (Ramos-Campoy et al., 2020).
Last Updated: 28 Oct 2021
References
Paper Citations
- Ramos-Campoy O, Antonell A, Falgàs N, Balasa M, Borrego-Écija S, Rodríguez-Santiago B, Datta D, Armengol L, Fernández-Villullas G, Bosch B, Olives J, Muñoz-García C, Castellví M, Tort-Merino A, Sánchez-Valle R, Lladó A. Screening of dementia genes by whole-exome sequencing in Spanish patients with early-onset dementia: likely pathogenic, uncertain significance and risk variants. Neurobiol Aging. 2020 Sep;93:e1-e9. Epub 2020 Feb 18 PubMed.
- Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL, ACMG Laboratory Quality Assurance Committee. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015 May;17(5):405-24. Epub 2015 Mar 5 PubMed.
Further Reading
No Available Further Reading
Protein Diagram
Primary Papers
- Ramos-Campoy O, Antonell A, Falgàs N, Balasa M, Borrego-Écija S, Rodríguez-Santiago B, Datta D, Armengol L, Fernández-Villullas G, Bosch B, Olives J, Muñoz-García C, Castellví M, Tort-Merino A, Sánchez-Valle R, Lladó A. Screening of dementia genes by whole-exome sequencing in Spanish patients with early-onset dementia: likely pathogenic, uncertain significance and risk variants. Neurobiol Aging. 2020 Sep;93:e1-e9. Epub 2020 Feb 18 PubMed.
Disclaimer: Alzforum does not provide medical advice. The Content is for informational, educational, research and reference purposes only and is not intended to substitute for professional medical advice, diagnosis or treatment. Always seek advice from a qualified physician or health care professional about any medical concern, and do not disregard professional medical advice because of anything you may read on Alzforum.
Comments
No Available Comments
Make a Comment
To make a comment you must login or register.